Science Current Events | Science News | Brightsurf.com
 

Cell skeleton may hold key to overcoming drug resistance in cancer

October 04, 2007
Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients.

A team of scientists at Children's Cancer Institute Australia for Medical Research (CCIA), led by Associate Professor Maria Kavallaris, discovered that the bIII-tubulin component of the cell's cytoskeleton could play an important role in resistance to a wide range of drugs used to treat lung, ovarian and breast cancers.

Advanced non-small cell lung carcinomas (NSCLC) account for more than 80 per cent of lung cancer cases. More than one million people are diagnosed with lung cancer every year, the most common cancer in the world and the leading cause of cancer deaths. Chemotherapy remains the most effective treatment option, involving a diverse range of drugs, often used in combination. However, the emergence of drug-resistant tumours in NSCLC means chemotherapy no longer holds the promise of a good outcome for many patients.

Increased expression of bIII-tubulin has been linked to drug resistance in NSCLC, ovarian and breast cancers. In the latest Cancer Research publication, Associate Professor Kavallaris and her team showed that blocking the expression of the bIII-tubulin gene in NSCLC cells led to an increase in their sensitivity to a range of chemotherapeutic drugs.

"Our results strongly suggest that the bIII-tubulin component is responsible for protecting NSCLC cells from the action of key chemotherapeutic drugs," said Associate Professor Kavallaris.

"This is the first scientific evidence for the broader implications of abnormal expression of this protein.

"We now have new insight into a mechanism of drug resistance in NSCLC which has not previously been reported. This has important implications for improving the targeting and treatment of a number of cancers which are resistant to current chemotherapeutic drugs," said Associate Professor Kavallaris.

Research Australia


Related Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles


Major discovery on the mechanism of drug resistance in leukemia and other cancers
A mechanism that enables the development of resistance to Acute Myeloid Leukemia (AML) anticancer drugs, thereby leading to relapse, has been identified by Kathy Borden of the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) and her collaborators.

Genetic aberration paves the way for new treatment of cancer disease
Researchers from Faculty of Health and Medical Sciences, University of Copenhagen, have characterized a genetic aberration on a group of colorectal cancer patients.

Nanotech system, cellular heating may improve treatment of ovarian cancer
The combination of heat, chemotherapeutic drugs and an innovative delivery system based on nanotechnology may significantly improve the treatment of ovarian cancer while reducing side effects from toxic drugs, researchers at Oregon State University report in a new study.

Celery, artichokes contain flavonoids that kill human pancreatic cancer cells
Celery, artichokes, and herbs, especially Mexican oregano, all contain apigenin and luteolin, flavonoids that kill human pancreatic cancer cells in the lab by inhibiting an important enzyme, according to two new University of Illinois studies.

More Effective Immunotherapy for Melanoma Hinges on Blocking Suppressive Factors, Moffitt Cancer Center Researchers Say
Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them.

CWRU School of Medicine researchers discover gene that permanently stops cancer cell proliferation
Researchers at Case Western Reserve University School of Medicine have discovered a mutant form of the gene, Chk1, that when expressed in cancer cells, permanently stopped their proliferation and caused cell death without the addition of any chemotherapeutic drugs.

Regulation by proteins outside cancer cells points to potential new drug target
Protein interactions outside breast cancer cells can send signals to the cancer cells to permanently stop proliferating, a new study showed in the School of Medicine at The University of Texas Health Science Center San Antonio.

Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
Researchers from the University of Notre Dame have engineered nanoparticles that show great promise for the treatment of multiple myeloma (MM), an incurable cancer of the plasma cells in bone marrow.

Experimental agent may help older people with chronic leukemia
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial.

Nanoparticles may enhance cancer therapy
A mixture of current drugs and carbon nanoparticles shows potential to enhance treatment for head-and-neck cancers, especially when combined with radiation therapy, according to new research by Rice University and the University of Texas MD Anderson Cancer Center.
More Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles

Physicians' Cancer Chemotherapy Drug Manual 2014 (Jones and Bartlett Series in Oncology(Physician's Cancer Chemotherapy Drug Manual))

Physicians' Cancer Chemotherapy Drug Manual 2014 (Jones and Bartlett Series in Oncology(Physician's Cancer Chemotherapy Drug Manual))
by Edward Chu (Author), Vincent T. DeVita Jr. (Author)


Completely revised and updated for 2014, the Physicians’ Cancer Chemotherapy Drug Manual 2014 is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers. Special features: • Revised to reflect rapid advances in the field • A specific chapter focused on profiling antiemetic drug and antiemetic treatment regimens. • Diagrams of drug structures and pathways for many of the agents. • Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages....

2014 Oncology Nursing Drug Handbook

2014 Oncology Nursing Drug Handbook
by Gail M. Wilkes (Author), Margaret Barton-Burke (Author)


Written especially for nurses caring for patients with cancer, the 2014 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2014 Oncology Nursing Drug Handbook includes: * New chapter on Chemobiotherapy for Noncancer Diseases * Specific drugs described in terms of their mechanism of action, metabolism, drug interactions, laboratory effects/interference, and special considerations * The most important and common drug side effects * Greater...

MedNotes: Pocket Drug Guide (Davis's Notes)

MedNotes: Pocket Drug Guide (Davis's Notes)
by Judith Hopfer Deglin PharmD (Author), April Hazard Vallerand PhD RN FAAN (Author)


A DAVIS’S NOTES BOOK! Instant access to all of the essential medical information you need! Drawing on the content of its best-selling parent reference, Davis’s Drug Guide for Nurses, it provides essential information on over 170 top medications commonly prescribed in acute and ambulatory care, including high-alert and emergency drugs! Quickly find content on patient safety—with vital information on pediatric and geriatric considerations—as well as precautions for all vulnerable populations.

Basic and Clinical Pharmacology 12/E (LANGE Basic Science)

Basic and Clinical Pharmacology 12/E (LANGE Basic Science)
by Bertram Katzung (Author), Susan Masters (Author), Anthony Trevor (Author)


The most up-to-date, comprehensive, and authoritative pharmacology text in health medicine Enhanced by more than three hundred illustrations -- many in full color Organized to reflect the syllabi in many pharmacology courses and in integrated curricula, Basic & Clinical Pharmacology, 12e covers the important concepts students need to know about the science of pharmacology and its application to clinical practice. Selection of the subject matter and order of its presentation are based on the authors’ many years experience in teaching this material to thousands of medical, pharmacy, dental, podiatry, nursing, and other health science students. To be as clinically relevant as possible, the book includes sections that specifically address the clinical choice and use of drugs in patients...

Katzung & Trevor's Pharmacology Examination and Board Review,10th Edition (Katzung & Trevor's Pharmacology Examination & Board Review)

Katzung & Trevor's Pharmacology Examination and Board Review,10th Edition (Katzung & Trevor's Pharmacology Examination & Board Review)
by Anthony Trevor (Author), Bertram Katzung (Author), Susan Masters (Author), Marieke Knuidering-Hall (Author)


MORE THAN 1000 Q&As PREPARE YOU FOR MEDICAL PHARMACOLOGY COURSE EXAMS AND BOARD EXAMINATIONS From the authors of pharmacology's #1 textbook, Katzung & Trevor's Basic & Clinical Pharmacology, Twelfth Edition, this review delivers a clear, concise review of fundamental concepts backed by more than 1,000 review questions and answers. The chapter-based approach facilitates use with course notes or larger texts. Outstanding learning aids include: Short discussion of the major concepts that underlie basic principles or specific drug groups Explanatory figures and tables Review questions followed by answers and explanations Drug trees in drug-oriented chapters that visually organize drug groups A list of high-yield terms and definitions you need to know Skill Keeper Questions that prompt you to...

Drug Discovery: A History

Drug Discovery: A History
by Walter Sneader (Author)


Written by a leading authority with an excellent reputation and ability for writing a good narrative, Drug Discovery: A History is a far cry from simply a list of chemical structures.This lively new text considers the origins, development and history of medicines that generate high media interest and have a huge social and economic impact on society.Set within a wide historical, social and cultural context, it provides expanded coverage of pre-twentieth century drugs, the huge advances made in the twentieth century and the latest developments in drug research.Hallmark features:Up-to-the-minute information in drug researchVignettes of special and unusual information, and anecdotesDiscusses drug prototypes from all sourcesMore comprehensive than other volumes on history of drug...

Drug Discovery and Development, Vol. 1: Drug Discovery

Drug Discovery and Development, Vol. 1: Drug Discovery
by Mukund S. Chorghade (Editor)


This two volume set provides a comprehensive account of the entire sequence of operations involved in discovering a drug through the actual delivery of the drug to clinicians and medical practitioners. Includes case studies of the discovery of erythromycin analogs (antibiotics), Tagamet, and Ultiva (remifentanil)Discusses the discovery of agents for the treatment and management of bacterial infections, Parkinson's disease, psoriasis, ulcers and stomach pain, atopic dermatitis, asthma, and cancerContains chapters on combinatorial chemistry, molecular biology-based drug discovery, genomics, and chemogenomicsThe first volume of this set thoroughly describes conceptualizing a drug, creating a library of candidates for testing, screening those candidates for in vitro and in vivo activity,...

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)
by Benjamin Bonavida (Editor)


This book reviews novel approaches developed to reverse tumor cell resistance to chemo/immuno/radio-therapy and the use of various sensitizing agents in combination with various cytotoxics. It also introduces several current approaches developed by established investigators that are aimed at overcoming resistance. This is the first volume to compile studies on tumor cell sensitization. It will prove useful for students, scientists, clinicians and pharmaceutical companies.

The Organic Chemistry of Drug Design and Drug Action

The Organic Chemistry of Drug Design and Drug Action
by Richard B. Silverman Ph.D Organic Chemistry (Author)


This is a new approach to the teaching of medicinal chemistry. The knowledge of the physical organic chemical basis of drug design and drug action allows the reader to extrapolate to the many related classes of drugs described in standard medicinal chemistry texts. Students gain a solid foundation to base future research endeavors upon: drugs not yet developed are thus covered!


* Emphasizes the use of the principles of physical organic chemistry as a basis for drug design
* Discusses organic reaction mechanisms of clinically important drugs with mechanistic schemes
* Uses figures and literature references extensively throughout
* This text is not merely a "compilation of drugs and uses," but features selected drugs as examples of...

Drug Delivery in Oncology: From Basic Research to Cancer Therapy

Drug Delivery in Oncology: From Basic Research to Cancer Therapy
by Felix Kratz (Editor), Peter Senter (Editor), Henning Steinhagen (Editor)


In this first authoritative overview on modern cancer chemotherapy 121 international specialists have contributed their experience and recent data for what is likely to become the gold standard in the field.

The authors summarize knowledge gained over the past decade, from basic concepts to successful applications in the clinic, covering active and passive targeting strategies as well as tissue-specific approaches. All current and future targeted delivery systems are discussed, from ligand-based to antibody-based polymer-based systems, right up to micro- and nanoparticulate systems. A special section covers the delivery of nucleic acid therapeutics, such as siRNA, miRNA and antisense nucleotides. In each case, a description of the basic technique is followed by a discussion of the...

© 2014 BrightSurf.com